In summary, our studies have shown that SLC25A1 is an essential component of the tumor cell metabolism and have enlightened novel mechanisms and therapeutic perspectives for the treatment of resistant NSCLC tumors. The gene discussed is SLC25A1; the disease is non-small cell lung carcinoma.